4//SEC Filing
Friedl-Naderer Johanna 4
Accession 0001209191-22-016929
CIK 0001706431other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 11:35 AM ET
Size
7.2 KB
Accession
0001209191-22-016929
Insider Transaction Report
Form 4
Friedl-Naderer Johanna
Chief Business Officer, Global
Transactions
- Award
Common Stock
2022-03-02+90,000→ 90,000 total - Award
Stock Option (Right to Buy)
2022-03-02+45,000→ 45,000 totalExercise: $24.13Exp: 2032-03-01→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]25% of the shares subject to the stock option vest and become exercisable on March 2, 2023, and the remainder vest in 36 equal monthly installments thereafter.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001915598
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 11:35 AM ET
- Size
- 7.2 KB